PURPOSE: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.
PURPOSE: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.